✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Vimta Labs Ltd.

VIMTALABS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,064 Cr.
P/E
43.39

Vimta Labs Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
3,064 Cr
PE
PE
43.39
Prom Holding
Prom Holding
36.67 %
ROE (%)
ROE (%)
17.78
ROCE (%)
ROCE (%)
22.95
Div Yield (%)
Div Yield (%)
0.29
Sales
Sales
363 Cr
OPM (%)
OPM (%)
35.20 %
Debt to Equity
Debt to Equity
0.02
View more
Edit Ratio's
About
Vimta Labs Limited, established in 1984, provides analytical, clinical, preclinical services t… Read more
Low
242
52W Range
High
728
  • Vimta Labs
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Vimta Labs Ltd. Business

    Founded in 1984, Vimta Labs Limited provides analytical, clinical, and preclinical services to life sciences industries, quality testing for food and beverage sectors, and environmental services globally.

    Vimta Labs major competitors are Krsnaa Diagnostics, Nidan Labs. & Health, Thyrocare Tech., Metropolis Health., Vijaya Diagnostic, Dr. Lal Pathlabs, Amrutanjan Healthcar.
    Market Cap of Vimta Labs is ₹3,064 Crs.
    While the median market cap of its peers are ₹7,013 Crs.

    Vimta Labs seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jul Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Apr Jul Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Mar Jun Sep Mar Jun Sep Dec Mar Sep Dec Mar Sep Mar Sep Dec Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Vimta Labs Ltd.
    View the discussion on ValuePickr
    Vimta Labs Ltd – Bet on the emerging theme of Contract Research & Testing Outsourcing - SOC Invest
    []
    Hospital Sector
    The Business Model of Indian Hospitals Simplified - Anish Moonka
    Effect Of Lease Accounting Changes & Why Debt To Equity Is Rising - SOIC
    Case Mix Of Hospitals - Harshit Toshniwal
    Hospital Sector Deep Dive! Part 2 - Who pays our bills? Payor mix, Profitability of payor types - Harshit Toshniwal
    Hospital Sector Deep Dive! Part 3 - Unit Economics, IRR of Hospital bus., Doctor Engagement Models - Harshit Toshniwal
    Hospital Sector Deep Dive! Part 7 - Stock preference in India Hospital Space - Harshit Toshniwal
    Medical Costs - India vs Abroad - Trade Brains
    A thread on the Medical Tourism in India - Aditya Kondawar
    How The Diagnostics Industry Works - PPFAS
    Diagnostic Industry - P2P Analysis - SOIC
    Impact on compeitition like TATA1MG on Diagnostics Sector - Aditya Khemka(Incred) - Bloomberg Quint
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material